United States · FDA National Drug Code directory
Glyburide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-9433_84b83205-8813-494e-933e-a70697393744
- Product NDC
- 0093-9433
- Form
- TABLET
- Composition / generic term
- glyburide
- Labeler
- TEVA Pharmaceuticals USA Inc
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 19840501
- Source listing expiry
- 20261231
Source-listed ingredients
- GLYBURIDE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (0093-9433-01) · 0093-9433-01
- 500 TABLET in 1 BOTTLE (0093-9433-05) · 0093-9433-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →